Thromboembolic Events

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-04-03
Clinical Trial Update: Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD) [Phase 4]
Phase 4 clinical trial comparing Lovenox 30 mg twice daily versus 40 mg once daily in trauma/surgery patients, currently recruiting.